Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus

被引:145
作者
McDowell, P
Affas, Z
Reynolds, C
Holden, MTG
Wood, SJ
Saint, S
Cockayne, A
Hill, PJ
Dodd, CER
Bycroft, BW
Chan, WC
Williams, P [1 ]
机构
[1] Univ Nottingham, Inst Infect & Immun, Nottingham NG7 2RD, England
[2] Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England
[3] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England
关键词
D O I
10.1046/j.1365-2958.2001.02539.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Staphylococcus aureus, the agr locus is responsible for controlling virulence gene expression via quorum sensing. As the blockade of quorum sensing offers a novel strategy for attenuating infection, we sought to gain novel insights into the structure, activity and turnover of the secreted staphylococcal autoinducing peptide (AIP) signal molecules. A series of analogues (including the L-alanine and D-amino acid scanned peptides) was synthesized to determine the functionally critical residues within the S. aureus group I AIP. As a consequence, we established that (I) the group I AIP is inactivated in culture supernatants by the formation of the corresponding methionyl sulphoxide; and (ii) the group I AIP lactam analogue retains the capacity to activate agr, suggesting that covalent modification of the AgrC receptor is not a necessary prerequisite for agr activation. Although each of the D-amino acid scanned AIP analogues retained activity, replacement of the endocyclic amino acid residue (aspartate) located C-terminally to the, central cysteine with alanine converted the group I AIP from an activator to a potent inhibitor. The screening of clinical S. aureus isolates for novel AIP groups revealed a variant that differed from the group I AIP by a single amino acid residue (aspartate to tyrosine) in the same position defined as critical by alanine scanning. Although this AIP inhibits group I S. aureus strains, the producer strains possess a functional agr locus dependent on the endogenous peptide and, as such, constitute a fourth S. aureus AIP pheromone group (group IV). The addition of exogenous synthetic AIPs to S. aureus inhibited the production of toxic shock syndrome toxin (TSST-1) and enterotoxin C3, confirming the potential of quorum-sensing blockade as a therapeutic strategy.
引用
收藏
页码:503 / 512
页数:10
相关论文
共 39 条
  • [1] THE ACCESSORY GENE REGULATOR (AGR) CONTROLS STAPHYLOCOCCUS-AUREUS VIRULENCE IN A MURINE ARTHRITIS MODEL
    ABDELNOUR, A
    ARVIDSON, S
    BREMELL, T
    RYDEN, C
    TARKOWSKI, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (09) : 3879 - 3885
  • [2] Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus
    Balaban, N
    Goldkorn, T
    Nhan, RT
    Dang, LB
    Scott, S
    Ridgley, RM
    Rasooly, A
    Wright, SC
    Larrick, JW
    Rasooly, R
    Carlson, JR
    [J]. SCIENCE, 1998, 280 (5362) : 438 - 440
  • [3] ESTERIFICATION OF PARTIALLY PROTECTED PEPTIDE-FRAGMENTS WITH RESINS - UTILIZATION OF 2-CHLOROTRITYLCHLORIDE FOR SYNTHESIS OF LEU-15-GASTRIN-I
    BARLOS, K
    GATOS, D
    KAPOLOS, S
    PAPAPHOTIU, G
    SCHAFER, W
    YAO, WQ
    [J]. TETRAHEDRON LETTERS, 1989, 30 (30) : 3947 - 3950
  • [4] BARLOS K, 1991, INT J PEPT PROT RES, V37, P513
  • [5] SYNTHESIS OF PROTECTED PEPTIDE-FRAGMENTS USING SUBSTITUTED TRIPHENYLMETHYL RESINS
    BARLOS, K
    GATOS, D
    KALLITSIS, J
    PAPAPHOTIU, G
    SOTIRIU, P
    YAO, WQ
    SCHAFER, W
    [J]. TETRAHEDRON LETTERS, 1989, 30 (30) : 3943 - 3946
  • [6] BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828
  • [7] Chan W., 1999, Fmoc solid phase peptide synthesis: a practical approach
  • [8] DIMINISHED VIRULENCE OF A SAR(-)/AGR(-) MUTANT OF STAPHYLOCOCCUS-AUREUS IN THE RABBIT MODEL OF ENDOCARDITIS
    CHEUNG, AL
    EBERHARDT, KJ
    CHUNG, E
    YEAMAN, MR
    SULLAM, PM
    RAMOS, M
    BAYER, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) : 1815 - 1822
  • [9] Crossley KB., 1997, STAPHYLOCOCCI HUMAN
  • [10] Dunny GM, 1999, CELL-CELL SIGNALING IN BACTERIA, P1